In HCC, angiogenesis is driven by several growth factors and signaling pathways, including VEGF and its receptors (VEGFRs), platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and the angiopoietin/Tie2 system [116]. Here, VEGFA is linked to hepatocellular carcinoma.